Doug Vandevelde - WK Kellogg Chief Officer
| KLG Stock | 20.05 0.24 1.18% |
Executive
Doug Vandevelde is Chief Officer of WK Kellogg Co
| Age | 58 |
| Address | One Kellogg Square, Battle Creek, MI, United States, 49016-3599 |
| Phone | 269 401 3000 |
| Web | https://www.wkkellogg.com |
WK Kellogg Management Efficiency
The company has Return on Asset of 0.0526 % which means that on every $100 spent on assets, it made $0.0526 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2334 %, implying that it generated $0.2334 on every 100 dollars invested. WK Kellogg's management efficiency ratios could be used to measure how well WK Kellogg manages its routine affairs as well as how well it operates its assets and liabilities. The WK Kellogg's current Return On Capital Employed is estimated to increase to 0.15, while Return On Tangible Assets are forecasted to increase to (0.05). At this time, WK Kellogg's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The WK Kellogg's current Other Assets is estimated to increase to about 7.2 M, while Total Assets are projected to decrease to roughly 1.6 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sarah Comstock | Merit Medical Systems | N/A | |
| John Brennan | Life Time Group | N/A | |
| Mark Butler | Merit Medical Systems | N/A | |
| Esq III | Xponential Fitness | 44 | |
| Kevin Beygi | Xponential Fitness | N/A | |
| Brian Lloyd | Merit Medical Systems | 63 | |
| Parham Javaheri | Life Time Group | 48 | |
| Ernest Toth | Aquestive Therapeutics | 66 | |
| Eric Simon | Xponential Fitness | N/A | |
| Danyal Ali | Xponential Fitness | N/A | |
| MBA MD | Aquestive Therapeutics | 68 | |
| CCN ND | Life Time Group | N/A | |
| Jake CPA | The Joint Corp | 43 | |
| Keith Dieruf | Life Time Group | N/A | |
| Robert Arnold | Aquestive Therapeutics | N/A | |
| Justin Hill | Sony Group Corp | N/A | |
| Jake Singleton | The Joint Corp | 42 | |
| R Singh | Life Time Group | 52 | |
| JoAnne Alkire | Merit Medical Systems | N/A | |
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
| Ricardo Alvarez | Merit Medical Systems | N/A | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0526 |
WK Kellogg Leadership Team
Elected by the shareholders, the WK Kellogg's board of directors comprises two types of representatives: WK Kellogg inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KLG. The board's role is to monitor WK Kellogg's management team and ensure that shareholders' interests are well served. WK Kellogg's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, WK Kellogg's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Ludmer, Chief Officer | ||
| Karen Duke, Vice Investor | ||
| Sherry BriceWilliamson, Chief Officer | ||
| Bill Rex, Chief Officer | ||
| Gary JD, Chairman CEO | ||
| Doug Vandevelde, Chief Officer | ||
| Lisa Walter, Chief Officer | ||
| Bruce Brown, Chief Officer | ||
| David McKinstray, Chief Officer | ||
| Mike Christensen, Chief Officer | ||
| Gary Pilnick, CEO Director | ||
| Norma BarnesEuresti, Chief Secretary | ||
| Stacy Flathauto, Chief Officer | ||
| Shannon Bible, Chief Officer |
KLG Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is WK Kellogg a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0526 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 2.34 B | ||||
| Shares Outstanding | 86.1 M | ||||
| Shares Owned By Insiders | 11.83 % | ||||
| Shares Owned By Institutions | 88.17 % | ||||
| Number Of Shares Shorted | 12.3 M | ||||
| Price To Book | 5.51 X |
Currently Active Assets on Macroaxis
When determining whether WK Kellogg is a strong investment it is important to analyze WK Kellogg's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact WK Kellogg's future performance. For an informed investment choice regarding KLG Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in WK Kellogg Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Packaged Foods & Meats space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WK Kellogg. If investors know KLG will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about WK Kellogg listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.204 | Dividend Share 0.64 | Earnings Share 0.82 | Revenue Per Share | Quarterly Revenue Growth (0.02) |
The market value of WK Kellogg is measured differently than its book value, which is the value of KLG that is recorded on the company's balance sheet. Investors also form their own opinion of WK Kellogg's value that differs from its market value or its book value, called intrinsic value, which is WK Kellogg's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WK Kellogg's market value can be influenced by many factors that don't directly affect WK Kellogg's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WK Kellogg's value and its price as these two are different measures arrived at by different means. Investors typically determine if WK Kellogg is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WK Kellogg's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.